The Life Science Market To Move Away From Insipidness, Reach US$ 4,200 Million

Posted by Ashish on May 4th, 2021

The Life Science Market report tabled by PersistenceMarketResearch focuses on the parameters of the 4th industrial revolution, which includes technology-driven healthcare solutions, with several breakthroughs in this regard. The entire supply chain – right from diagnostics to the delivery of medicines, is being driven by the technological advancements in healthcare.

According to a study conducted by Persistence Market Research (PMR) on the global market for life science products, incessant progress in the field of biotech science has led to the development of various new-age and consumer-friendly life science products in recent years. The PMR study reveals that the global life science products market is set to witness a CAGR of over 4% in terms of revenue between 2016 -2024. The market is expected to create an absolute $ opportunity of US$ 114.9 Million in 2017 over 2016.

Availability of advanced technological support and a continuously expanding information database owing to intensive analysis and combined research expeditions on various life science topics has resulted in the development of novel therapeutics. Accordingly, the arrival of latest antibody manufacturing methods has greatly improved the overall propositions of scientific research and analysis activities.

Planning Forward? Access Sample Of Life Science Market Report! https://www.persistencemarketresearch.co/samples/9986

Company Profiles 

• Abcam Plc
• A.M.S. Biotechnology (Europe) Limited
• Bio-Rad Laboratories Inc.
• BPS Bioscience Inc.
• Crown Bioscience Inc.
• Genscript Biotech Corporation
• Merck Millipore Limited
• PerkinElmer Inc.
• Sigma Aldrich Corp.
• Thermo Fisher Scientific Inc.